EcoDrugPlus

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSMOCG00000018236
Gene Symbol: GRM4
3 Cross references
273 Possible Orthologues:

Glutamate Receptor, Metabotropic 5

Ensembl ID : ENSMOCG00000007786
Gene Symbol: GRM5
1 Cross references
271 Possible Orthologues:

Glutaminase

Ensembl ID : ENSMOCG00000021786
Gene Symbol: GLS
3 Cross references
305 Possible Orthologues:

Glutathione S-Transferase P

Ensembl ID : ENSMOCG00000020246
Gene Symbol: LOC101982378
2 Cross references
167 Possible Orthologues:

Glutathione S-Transferase P-Like

Ensembl ID : ENSMOCG00000007404
Gene Symbol: LOC101984224
2 Cross references
167 Possible Orthologues:

Glutathione S-Transferase P-Like

Ensembl ID : ENSMOCG00000003646
Gene Symbol: LOC101979334
2 Cross references
167 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSMOCG00000013617
Gene Symbol: GSK3A
3 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSMOCG00000003748
Gene Symbol: GSK3B
3 Cross references
241 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSMOCG00000007348
Gene Symbol: GNRHR
3 Cross references
454 Possible Orthologues:

Group 10 Secretory Phospholipase A2

Ensembl ID : ENSMOCG00000005669
Gene Symbol: LOC101993128
3 Cross references
249 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSMOCG00000001328
Gene Symbol: GHRHR
3 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSMOCG00000010453
Gene Symbol: GHSR
3 Cross references
212 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).